Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medizone International, Inc. MZEI


Primary Symbol: MZEIQ

Healthcare Medical Devices
Medizone International Inc is the business of disinfection. The firm's primary focus is hospital disinfection. Its main product is AsepticSure. It is an ozone-based disinfectant formula used for disinfection of surfaces in hospitals, clinics, hotels, sporting venues and also in the food industry and long-term care facilities and other infrastructures.


PINL:MZEIQ - Post by User

Medizone International, Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Casey25on Jul 01, 2012 12:13pm
495 Views
Post# 20073450

Latest Breakthrough

Latest Breakthrough

Below is just an excerpt, but this is very promising for Medizone.  THOUGHTS?

SAN FRANCISCO, June 12, 2012 /PRNewswire via COMTEX News Network/ -- Medizone International, Inc. (The Company) (MZEI:OB) (MZEI:QB) announced today that in achieving 100% kill rates with TB in three successive trials, it had achieved another important milestone in its understanding of the antimicrobial limits of its recently launched disinfection technology, AsepticSure(TM).

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities